0 Évaluations
ID

31183

Description

Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin Please record all concomitant medications and transfusions from the time of study entry through the Week 13 visit. Include study-required medications (i.e. Lugol's solution or potassium iodide, paracetamol, and diphenhydramine).

Mots-clés

Versions (1)
  1. 25/07/2018 25/07/2018 -
Détendeur de droits

see clinicaltrials.gov

Téléchargé le

25 juillet 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755

    Anglais

    Concomitant Medications & Transfusions

    1 Formulaires  
    Administrative Data
    Description

    Administrative Data

    Alias
    UMLS CUI-1
    C1320722
    Site Number
    Description

    Site number

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C0018704
    UMLS CUI [1,2]
    C0600091
    Patient Number
    Description

    Patient Number

    Type de données

    text

    Alias
    UMLS CUI [1]
    C1830427
    Patient Initials
    Description

    Patient Initials

    Type de données

    text

    Alias
    UMLS CUI [1]
    C2986440
    Concomitant Medications; Concomitant Transfusions
    Description

    Concomitant Medications; Concomitant Transfusions

    Alias
    UMLS CUI-1
    C2347852
    Drug Name or Blood Product
    Description

    Concomitant Agent; Drug Name or Blood Product

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C2360065
    UMLS CUI [1,3]
    C0456388
    Dose
    Description

    Concomitant Agent; Dose

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C3174092
    Unit
    Description

    Concomitant Agent; Unit

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C1519795
    Route
    Description

    Concomitant Agent; Route

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C0013153
    Frequency
    Description

    Concomitant Agent; Frequency

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C3476109
    Start Date
    Description

    Concomitant Agent; Start Date

    Type de données

    date

    Alias
    UMLS CUI [1]
    C2826734
    End Date
    Description

    Concomitant Agent; End Date

    Type de données

    date

    Alias
    UMLS CUI [1]
    C2826744
    Retour au début de la page

    Similar models

    Concomitant Medications & Transfusions

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    Administrative Data
    C1320722 (UMLS CUI-1)
    Site number
    Item
    Site Number
    text
    C0018704 (UMLS CUI [1,1])
    C0600091 (UMLS CUI [1,2])
    Patient Number
    Item
    Patient Number
    text
    C1830427 (UMLS CUI [1])
    Patient Initials
    Item
    Patient Initials
    text
    C2986440 (UMLS CUI [1])
    Item Group
    Concomitant Medications; Concomitant Transfusions
    C2347852 (UMLS CUI-1)
    Concomitant Agent; Drug Name or Blood Product
    Item
    Drug Name or Blood Product
    text
    C2347852 (UMLS CUI [1,1])
    C2360065 (UMLS CUI [1,2])
    C0456388 (UMLS CUI [1,3])
    Concomitant Agent; Dose
    Item
    Dose
    text
    C2347852 (UMLS CUI [1,1])
    C3174092 (UMLS CUI [1,2])
    Concomitant Agent; Unit
    Item
    Unit
    text
    C2347852 (UMLS CUI [1,1])
    C1519795 (UMLS CUI [1,2])
    Concomitant Agent; Route
    Item
    Route
    text
    C2347852 (UMLS CUI [1,1])
    C0013153 (UMLS CUI [1,2])
    Concomitant Agent; Frequency
    Item
    Frequency
    text
    C2347852 (UMLS CUI [1,1])
    C3476109 (UMLS CUI [1,2])
    Concomitant Agent; Start Date
    Item
    Start Date
    date
    C2826734 (UMLS CUI [1])
    Concomitant Agent; End Date
    Item
    End Date
    date
    C2826744 (UMLS CUI [1])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial